Eight alkaloids, including a new compound, (+)-norboldine acetate (1), and seven known ones, (+)-norboldine (2), (+)-boldine (3), (+)-laurotetanine (4), (+)-N-methyllaurotetanine (5), (+)-reticuline (6), (−)-pronuciferine (7), and pallidine (8) were isolated from the roots of Lindera aggregata. The structures of these alkaloids were determined by spectroscopic and chemical methods, especially 2D NMR techniques, which also allowed the first full NMR assignments of alkaloids 2, 4 and 5. Among them, the 1D NMR chemical shifts of (+)-norboldine (2) showed a remarkable environmental sensitive behavior. All the alkaloids were tested in cytotoxicity assays against L1210 and K562 tumor cell lines; only (+)-norboldine (2) showed weak activity against the L1210 cell line.
Lindera aggregata (Sims.) Kosterm. [L. strychnifolia (Sieb. et Zucc.) F. Vill.] (Lauraceae) is an evergreen shrub widely distributed in southern China, Japan and southeastern Asia [1] . In China and Japan, the dry root of L. aggregata is a well-known traditional herbal medicine and has been applied in the treatment of cardiac, renal, cystic and rheumatic diseases for hundreds of years [2] . Previous phytochemical investigations have demonstrated that isoquinoline alkaloids [3a-3c] , sesquiterpene lactones [3d], flavonoids [3e], and tannins [3f] were four main bioactive components of L. aggregata, among which the alkaloids have showed potential antitumor, anti-inflammatory, antiviral, antimicrobial and antidiabetic activities [3g,4] , and aroused extensive interest for pharmaceutical researchers. However, the NMR data of some of these alkaloids were assigned empirically without 2D NMR support or only for easily distinguishable signals [5] . In the present study, a new compound, (+)-norboldine acetate (1), was isolated together with 7 known alkaloids (2) (3) (4) (5) (6) (7) (8) .
(+)-Norboldine acetate (1) was isolated as a hazel amorphous solid. Its positive and negative ESI-MS showed pseudo molecular ion peaks at m/z 314 and 312, respectively, the same as (+)norboldine (2) . The positive HR-ESI-MS revealed a The structures of alkaloids 2-8 were determined from their specific optical rotations and by analysis of 2D NMR data. In brief, the 1 H NMR assignments of (+)-norboldine (2) have been partially reported previously [7] [8] [9] . In the present study, we report the first full 1 H and 13 C NMR assignments for 2, (+)laurotetanine (4) In the present study, compound 2a was isolated. Its 1 H and 13 C NMR spectra showed significant differences compared with those of 2, especially in the δ 2.4 ~ 4.2 region of the 1 H NMR spectra ( Figure  2 ) and δ 120 ~ 132 and δ 25 ~ 45 regions in the 13 C NMR spectra ( Figure 3 ). However, subsequent ESIMS and 2D NMR studies (HSQC, HMBC, and NOESY) showed that the structure of 2a was identical to that of 2. In order to clarify whether this phenomenon was induced by different environments in the solvent, a mixture of 2 and 2a (1:1) was subjected to NMR studies. Interestingly, the resulting spectra of the mixture split the difference, which revealed that the differences in NMR spectra of 2 and 2a were induced by different environments.
Compared to the reported NMR data for (+)-norboldine, the spectrum of 2 was similar to that reported in reference 7, while the spectrum of 2a was more similar to that in reference 8 and 9.
The in vitro activities of alkaloids 1-8 were tested against the mouse lymphocytic leukemia L1210 and (1:1) in CD 3 OD. suspension and adjusted to pH ≈ 3 with 2 M HCl. The acidic suspension was first partitioned with CHCl 3 (1 L × 3) to remove the neutral components. The aqueous phase was then basified with 5% Na 2 CO 3 to pH ≈ 10 and extracted with CHCl 3 (1 L × 3) to obtain 32 g of crude alkaloids. These were subjected to an MCI gel column (H 2 O-EtOH, 1:0-0:1) to give six major fractions 1-6. Fraction 1 was separated on a silica gel column (CHCl 3 -CH 3 OH, 20:1) to give three subfractions 1a-1c. Fraction 1a was further purified on a Sephadex LH-20 gel column (EtOH) to give compound 8 (38 mg). Fraction 1b was separated on a RP-18 column (30% aqueous EtOH) to give 3 (25 mg). Fraction 1c was further purified on a silica gel column (EtOAc-CH 3 OH-Et 2 NH, 20:1:0.1) to give alkaloid 2 (300 mg). Fraction 2 was separated on a RP-18 column and a Sephadex LH-20 gel column (EtOH) to give compound 2a (19 mg). Fraction 5 was further purified by silica gel column chromatography (CHCl 3 -CH 3 OH, 25:1) to give 4 subfractions 5a-5d. 5b was purified on a silica gel column (EtOAc-CH 3 OH-Et 2 NH, 20:1:0.1) to give compound 6 (68 mg). 5d was further purified by preparative TLC (CHCl 3 -MeOH, 3:1) to give compound 1 (12 mg). Fraction 6 was further separated on a silica gel column (CHCl 3 -CH 3 OH, 50:1) to give 3 fractions 6a-6c. Subsequent chromatography of 6a on a silica gel column (light petroleum-EtOAc-Et 2 NH, 2:1:0.1) gave compound 7 (11 mg). Fraction 6b was further purified on a Sephadex LH-20 gel column (EtOH) to give compound 5 (15 mg). Separation of fraction 6c by preparative TLC (EtOAc-CH 3 OH-Et 2 NH, 10:1:0.1) gave compound 4 (9 mg). (1): To a solution of 2 (6 mg) in 2 mL aqueous MeOH, 0.5 mL acetic acid was added and the reaction mixture stirred for 0.5 h at room temperature. Usual workup following preparative TLC (CHCl 3 -MeOH, 3:1) afforded 1. ( 
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